Cannabis Bioscience International Holdings Announces Effectiveness of Form S-1 Registration Statement
HOUSTON, TX , Dec. 06, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that its registration statement on Form S-1 (File No. 333-267039) (the “Registration Statement”), filed under the Securities Act of 1933 (the “Securities Act”), was declared effective by the United States Securities and Exchange Commission (the “SEC”) on December 5, 2023. This declaration does not imply that the SEC has approved or disapproved the offer or sale of the common stock offered by the prospectus that is part of the registration statement (the “Prospectus”) or determined whether the Prospectus is truthful or complete. The Company filed the Registration Statement to register the offer and sale of 10,087,154,885 shares of its common stock at a price of $0.0008 per share. The Company is offering 6,250,000,000 of these shares and the remaining 3,837,154,885 shares may be offered by selling stockholders. The Company will receive none of the proceeds of sales by the selling stockholders. The Company has become a reporting company under Section 15(d) of the Securities Exchange Act of 1934 and is required to file annual, quarterly and other reports with the SEC thereunder. These reports will be available at www.sec.gov.